Alnylam Joins Alliance for Genomic Discovery

MT Newswires Live09-18 22:33

Illumina (ILMN) and Nashville Biosciences said Thursday that Alnylam Pharmaceuticals (ALNY) has joined the Alliance for Genomic Discovery.

Alnylam will use the alliance's genomic database to boost drug target discovery, the companies said.

Alnylam is the ninth member of the alliance joining AbbVie (ABBV), Amgen (AMGN), AstraZeneca (AZN), Bayer, Bristol Myers Squibb (BMY), GSK (GSK), Merck (MRK), and Novo Nordisk (NVO), the companies said.

Price: 103.16, Change: +2.29, Percent Change: +2.27

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法